UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally

The Journal of immunology (1950), 2017-01, Vol.198 (1), p.31-39

2017

Volltextzugriff (PDF)

Repurposing the yellow fever vaccine for intratumoral immunotherapy

EMBO molecular medicine, 2020-01, Vol.12 (1), p.e10375-n/a

2020

Volltextzugriff (PDF)

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

Cancer discovery, 2016-01, Vol.6 (1), p.71-79

2016

Volltextzugriff (PDF)

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002054

2021

Volltextzugriff (PDF)

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

Cancer cell, 2019-12, Vol.36 (6), p.613-629.e7

2019

Volltextzugriff (PDF)

Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

European journal of immunology, 2016-03, Vol.46 (3), p.513-522

2016

Volltextzugriff (PDF)

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming

Cancer research (Chicago, Ill.), 2018-12, Vol.78 (23), p.6643-6654

2018

Volltextzugriff (PDF)

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

Oncoimmunology, 2017-04, Vol.6 (4), p.e1283468-e1283468

2017

Volltextzugriff (PDF)

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity

Cancer immunology research, 2022-11, Vol.10 (11), p.1354-1369

2022

Volltextzugriff (PDF)

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation

Cancer immunology research, 2018-07, Vol.6 (7), p.798-811

2018

Volltextzugriff (PDF)

Cellular cytotoxicity is a form of immunogenic cell death

Journal for immunotherapy of cancer, 2020-03, Vol.8 (1), p.e000325

2020

Volltextzugriff (PDF)

Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade

Cancer immunology research, 2015-05, Vol.3 (5), p.449-454

2015

Volltextzugriff (PDF)

Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti–PD-1 and Anti-CD137 Monoclonal Antibodies

Journal of thoracic oncology, 2016-04, Vol.11 (4), p.524-536

2016

Volltextzugriff (PDF)

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism

Oncoimmunology, 2016-01, Vol.5 (1), p.e1062967-e1062967

2016

Volltextzugriff (PDF)

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

Cancer research (Chicago, Ill.), 2016-10, Vol.76 (20), p.5994-6005

2016

Volltextzugriff (PDF)

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

Molecular therapy, 2019-11, Vol.27 (11), p.1892-1905

2019

Volltextzugriff (PDF)

CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8 + T Cell-Relevant Genes

Cancer immunology research, 2018-01, Vol.6 (1), p.69-78

2018

Volltextzugriff (PDF)

Abstract 4012: Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4012-4012

2016

Volltextzugriff (PDF)

Immunology of COVID-19: Current State of the Science

Immunity (Cambridge, Mass.), 2020-06, Vol.52 (6), p.910-941

2020

Volltextzugriff (PDF)

Abstract 1474: Repurposing the yellow fever vaccine for intratumoral immunotherapy

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1474-1474

2019

Volltextzugriff (PDF)

Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4908-4908

2016

Volltextzugriff (PDF)

Co-stimulation Agonists via CD137, OX40, GITR, and CD27 for Immunotherapy of Cancer

Oncoimmunology, p.429-446

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(21)
Buchkapitel
(1)

Sprache

Englisch
(22)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Animals
(15)
Mice
(12)
Oncology
(12)
Immunology
(10)
Humans
(9)
Immunotherapy
(9)
Cd8-Positive T-Lymphocytes - Immunology
(8)
Cell Line, Tumor
(6)
Dendritic Cells - Immunology
(6)
Female
(6)
Lymphocytes
(6)
Mice, Inbred C57bl
(5)
Antibodies, Monoclonal - Therapeutic Use
(4)
Antigens
(4)
Cancer
(4)
Cancer Immunotherapy
(4)
Cd8-Positive T-Lymphocytes - Metabolism
(4)
Lymphocytes, Tumor-Infiltrating - Immunology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally

Repurposing the yellow fever vaccine for intratumoral immunotherapy

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells

Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells

Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy

Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming

CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes

Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity

Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) Costimulation

Cellular cytotoxicity is a form of immunogenic cell death

Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade

Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti–PD-1 and Anti-CD137 Monoclonal Antibodies

Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming

Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor Responses

CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8 + T Cell-Relevant Genes

Abstract 4012: Improving radiotherapy abscopal effects with anti-PD1 and anti-CD137-based immunotherapy

Immunology of COVID-19: Current State of the Science

Abstract 1474: Repurposing the yellow fever vaccine for intratumoral immunotherapy

Abstract 4908: Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires Batf3-dependent dendritic cells

Co-stimulation Agonists via CD137, OX40, GITR, and CD27 for Immunotherapy of Cancer

Suchergebnisse filtern